Promising Practices Related To The Prevention, Control and Treatment of Hypertension David J. Hyman, MD, MPH Professor of Medicine and Family & Community.

Slides:

Advertisements

Similar presentations

Uncovering ED National Highlights. ED FACTS ED affects 2 to 3 million men in Canada Vascular disease is one of the leading causes of ED 1 Prevalence of.

Advertisements

Get to Goal, Achieve Control

1 Item code: Print date: Not applicable 1.

Critical Challenges in Cardiovascular Disease

Ten years of the CHD NSF Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health.

Patient Safety and Quality of Care: Role of the Compliance Professional Harvey V. Fineberg, M.D., Ph.D. Sixth Annual National Congress on Health Care Compliance.

The New Health Check up System in Japan for Metabolic Syndrome

Physicians for Healthy Communities Initiative: An obesity prevention project of the CMA Foundation.

Published Evidence for Value-Based Insurance Design Michael C. Sokol, MD, MS Corporate Medical Director Merck & Co., Inc.

TABLE OF CONTENTS CHAPTER 5.0: Workforce

TABLE OF CONTENTS CHAPTER 5.0: Workforce Chart 5.1: Total Number of Active Physicians per 1,000 Persons, 1980 – 2009 Chart 5.2: Total Number of Active.

Chapter 5: Workforce. Chartbook 2003 Physician Workforce After dropping slightly in 1999, the number of active physicians per thousand population rose.

DIVERSE COMMUNITIES, COMMON CONCERNS: ASSESSING HEALTH CARE QUALITY FOR MINORITY AMERICANS FINDINGS FROM THE COMMONWEALTH FUND 2001 HEALTH CARE QUALITY.

Heart Disease and Stroke Statistics 2011 Update 1.

Diabetes in Idaho BRFSS 2009 Data collected from Behavioral Risk Factor Surveillance System Idaho Department of Health and Welfare, Division of.

Connecticuts Value Based Insurance Design The Health Enhancement Program for Connecticut State Employees (Covers Active State Employees and Retirees After.

Robert M. Guthrie, MD Professor of Emergency Medicine

Randall M. Zusman, MD Associate Professor of Medicine

Hypertension: The Whole Story

Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center.

Jeannie Hayhurst Cardiovascular Specialist Nurse.

Reduced Incidence of ESRD among 60 to 80–year-olds in Denmark Heaf JG 1, Wehberg S 2, Engberg H 2 Danish Nephrology Registry 1 Herlev Hospital, University.

Nurse Led Clinics Opportunity for nurses to make a difference Wilma Scholte op Reimer, RN, PhD Amsterdam School of Health Professions Academic Medical.

CE REVIEW UNDERSTANDING HYPERTENSION. Hypertension is a chronic medical condition affecting more than 65 million Americans. Controlling hypertension is.

HYPERTENSION: AN OVERVIEW Prof Ahmed Mandil, Dr Hafsa Raheel KSU Dept of Family & Community Medicine.

Presented by: National Forum for Heart Disease and Stroke Prevention Improving Hypertension Control The Kaiser Permanente Hypertension Control Project:

Peripheral Arterial Disease: missed opportunity for cardiovascular intervention Subhash Banerjee, MD Chief, Division of Cardiology VA North Texas Healthcare.

THE CHALLENGE: CHRONIC DISEASE CARE AND THE PROMISE OF HIT Health Care Information Technology 2004: Improving Chronic Care in California San Francisco.

VBWG Synergistic actions of hypertension and dyslipidemia on endothelial function Implications for treatment Mason RP et al. Circulation. 2004;109(suppl.

HIV and Aging Kathleen K Casey, MD Director, AIDS Ambulatory Care Center Jersey Shore University Medical Center.

Lipid Management in 2015: Risk & Controversies

Adel E. Berbari, MD, FAHA, FACP Professor of Medicine and Physiology Head, Division of Hypertension and Vascular Medicine American University of Beirut-

Optimizing Treatment Of Heart Failure for individual patients By Prof. Mansoor Ahmad FRCP Consultant Cardiologist.

Stanford Prevention Research Center STANFORD SCHOOL OF MEDICINE National Trends in the Prescribing of Anti-Hypertensive Medications Jun Ma, MD, PhD Research.

Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP

Lesley Stevens MD Tufts-New England Medical Center

Management of Hypertension according to JNC 7 BY SANDAR KYI, MD.

Hypertension and Nutrition Haley Aimone What Is HYPERTENSION Chronic medical condition Blood pressure in arteries are elevated Can lead to heart disease,

Hypertension By Dr. Nagwa Eid Saad Prof. Of Internal Medicine & Family Medicine In Cairo University.

Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.

Improving the Care of the Hypertensive Patient: US Perspective William Cushman, MD Professor, Preventive Medicine and Medicine University of Tennessee.

1 Hypertension Overview. 2 Leading Risks For Death (World Health Organization 2002) Cholesterol Alcohol HYPERTENSION Tobacco use Overweight.

Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal

Systolic hypertension not an isolated problem Michael Weber, MD Professor of Medicine Associate Dean Downstate College of Medicine State University of.

DION GALLANT, MD PRIMARY CARE SERVICE LINE MEDICAL DIRECTOR PRESBYTERIAN MEDICAL GROUP JNC 8.

Hypertension (High Blood Pressure)

Combination Therapy for Hypertension Summary and Comment by Harlan M. Krumholz, MD, SM Published in Journal Watch Cardiology December 3, 2008Journal Watch.

Improving Hypertension Quality Measurement Using Electronic Health Records S Persell, AN Kho, JA Thompson, DW Baker Feinberg School of Medicine Northwestern.

Studying mortality trends: The IMPACT CHD Policy Model

HYPERTENSION Background for understanding the Hypertension literature. Jeffrey J. Kaufhold, MD Nephrology.

Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.

HYPERTENSION RECOMMENDATIONS FOR FOLLOW UP BASED ON INITIAL BP READING

Polypill x Aspirin Project Groups 3 and 4

Pre-ALLHAT Drug Use IMS Health NDTI, Year % of Treated Patients on Medication CCBs Beta Blockers Diuretics ACE Inhibitors.

Internal Medicine Workshop Series Laos September /October 2009.

Date of download: 6/28/2016 From: Effects of Blood Pressure Reduction in Mild Hypertension: A Systematic Review and Meta-analysis Ann Intern Med. 2015;162(3):

Management of Hypertension according to JNC 7

Hypertension guidelines What’s all the controversy about 2015

JNC VIII Hypertension.

Vanguard Phase Results for the Blood Pressure Component

Primary Efficacy End Point.

David J. Hyman, MD, MPH Professor of Medicine and

Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010

Primary Hypertension Max C. Reif, M.D.

Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level BP level (mm Hg) Adjusted relative risk 95%

Internal Medicine Workshop Series Laos September /October 2009

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.

Presentation transcript:

Promising Practices Related To The Prevention, Control and Treatment of Hypertension David J. Hyman, MD, MPH Professor of Medicine and Family & Community Medicine Baylor College of Medicine President elect - Texas Chapter of the American Society of Hypertension

Problems Hypertension is an extremely important Risk factor for heart disease, stroke, Renal failure, CHF and all the complications of diabetes Population BP has stopped going down About 35% of people with hypertension are still unaware of it About 35% of people being treated for hypertension are not controlled to target

Non-HispanicMexican- African- whiteAmerican American 27.4% 25.1 % 40.5% Age Standardized Prevalence of Hypertension in the United States National Health and Nutrition Survey (NHANES) ( )

Prevalence of Hypertension in the United States* *Based on NHANES data. Hypertension is defined as blood pressure 140/90 mmHg or antihypertensive treatment. Low reliability due to large relative error. Fields et al. Hypertension. 2004:44; Hypertension Prevalence Age

% of Treated Controlled 64 Hypertension Control in U.S. - NHANES Ong, Hypertension 2007 % of Treated Controlled 30 % of Treated Controlled 65 % of Treated Controlled 43 % of Treated Controlled 51

Primary Prevention of Hypertension via food supply sodium reduction: A growing international trend that TEXAS should join 1.3 gm average daily decrease will prevent 5mm/HG rise in BP with age and save 150,000 lives year - Most sodium is in processed food - Individual action is extremely difficult - Commercial alternatives exist - Food supply interventions are occurring around the world -Dickinson, AMA council of scientific affairs, archives IM 2007

England Department of Health and Food standards agency goal 2.4 gm sodium by food manufactures have signed on and begun to reduce Ireland Pressuring food industry New Zealand / Australia Strict labeling Industry pressure to reduce sodium has reduced Sodium in breads, cereals, margarine France Goal 20% reduction in 5 years Finland National focus since 1970s Sodium decrease from 4700 to 3300 Population decrease in blood pressure International Efforts

30% of Hypertensives Unaware!

Of the unaware hypertensives… Mexican Americans are very over represented But 90 % of Unaware have insurance 80% have a usual source of care 75% had a BP measurement in the last year 96% had a BP measurement in the last 4 years Mean age 58 Mean BP 148/83 Hyman NEJM 2001

Implication: New screening programs needed Hispanics Low utilizers Education programs needed for health providers and public on appropriate reaction to mild BP elevations New technologies and paradigms for BP measurement may be needed.

Improving control in treated patients Continue public and physician education Appreciate limits on scientific data on achieving goals Educate on the availability of low cost drugs

Hypertension Treatment by Drug Class CCB s ß-Blocker ACE Inhibitors Diuretics ARB s IMS Health NDTI,

Cost of market leaders Norvasc $84 month Valsartan $74 month What you can get for $ 4 per month from Walmart (web 9/07) ACE Benezepril Lisinopril B blocker Metoprolol (BID) Atenelol Carvedilol (BID) Thiazides* Clonidine* Lovastatin 10,20 Pravastatin 10-40

If BP drugs are cheap… Big pharma cant make any $ on BP Drugs… If big pharma controls the flow of medical information… and big pharma looses interest in Hypertension… The public health community will have to keep blood pressure control on the agenda by our selves!! The population will suffer if we dont.